PSUSA/00002024/202410

PSUSA/00000997/202410

Declaration of interest form: Public call for Scientific Advisory Group on Immune and Inflammatory Diseases

Scientific Advisory Group on Immune and Inflammatory Diseases

Public call for expression of interest for experts to become members of the European Medicines Agency's Scientific Advisory Group on Immune and Inflammatory Diseases

Human medicines European public assessment report (EPAR): Glivec, imatinib, Date of authorisation: 07/11/2001, Revision: 50, Status: Authorised

Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 21-24 July 2025

PRIME: priority medicines

List of medicines currently in PRIME scheme

Human medicines European public assessment report (EPAR): Mycamine, micafungin, Date of authorisation: 25/04/2008, Revision: 21, Status: Authorised